Jpmorgan Chase & CO Daxor Corp Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Daxor Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4 shares of DXR stock, worth $32. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 5
20.0%
Holding current value
$32
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DXR
# of Institutions
9Shares Held
96.6KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA49KShares$397,1260.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.1KShares$227,7800.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL15.9KShares$128,9030.07% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M03.13KShares$25,3360.0% of portfolio
-
Ubs Group Ag326Shares$2,6400.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $32.7M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...